Meanwhile, elevated serum S100A8/A9 levels 1 day after percutaneous coronary angioplasty (PCI) were found to be significantly associated with long-term adverse cardiovascular events in patients with acute myocardial infarction in the clinic (68). This evidence concerns the gene S100A8 and acute myocardial infarction.